You just read:

Taiho Oncology and Servier Announce Positive Results from LONSURF® (trifluridine/tipiracil) Study Presented at ESMO 2018 Congress and Published in The Lancet Oncology

News provided by

Taiho Oncology, Inc.

Oct 21, 2018, 05:10 ET